Abstract:Pharmaceuticals are of concern to our planet and health as they can accumulate in the environment. The impact of these biologically active compounds on ecosystems is hard to predict, and information on their biodegradation is necessary to establish sound risk assessment. Microbial communities are promising candidates for the biodegradation of pharmaceuticals such as ibuprofen, but little is known yet about their degradation capacity of multiple micropollutants at higher concentrations (100 mg/L). In this work, microbial communities were cultivated in lab-scale membrane bioreactors (MBRs) exposed to increasing concentrations of a mixture of six micropollutants (ibuprofen, diclofenac, enalapril, caffeine, atenolol, paracetamol). Key players of biodegradation were identified using a combinatorial approach of 16S rRNA sequencing and analytics. Microbial community structure changed with increasing pharmaceutical intake (from 1 to 100 mg/L) and reached a steady-state during incubation for 7 weeks on 100 mg/L. HPLC analysis revealed a fluctuating but significant degradation (30-100%) of five pollutants (caffeine, paracetamol, ibuprofen, atenolol, enalapril) by an established and stable microbial community mainly composed of Achromobacter, Cupriavidus, Pseudomonas and Leucobacter. By using the microbial community from MBR1 as inoculum for further batch culture experiments on single micropollutants (400 mg/L substrate, respectively), different active microbial consortia were obtained for each single micropollutant. Microbial genera potentially responsible for degradation of the respective micropollutant were identified, i.e. Pseudomonas sp. and Sphingobacterium sp. for ibuprofen, caffeine and paracetamol, Sphingomonas sp. for atenolol and Klebsiella sp. for enalapril. Our study demonstrates the feasibility of cultivating stable microbial communities capable of degrading simultaneously a mixture of highly concentrated pharmaceuticals in lab-scale MBRs and the identification of microbial genera potentially responsible for the degradation of specific pollutants. KEY POINTS: • Multiple pharmaceuticals were removed by stable microbial communities. • Microbial key players of five main pharmaceuticals were identified.

Removal of Pharmaceuticals and Personal Care Products by Ammonia Oxidizing Bacteria Acclimated in a Membrane Bioreactor: Contributions of Cometabolism and Endogenous Respiration.

Performance and microbial communities of different biofilm membrane bioreactors with pre-anoxic tanks treating mariculture wastewater

Biotransformation pathways of pharmaceuticals and personal care products (PPCPs) during acidogenesis and methanogenesis of anaerobic digestion

Elimination and fate of selected micro-organic pollutants in a full-scale anaerobic/anoxic/aerobic process combined with membrane bioreactor for municipal wastewater reclamation.

Removal of Pharmaceuticals and Personal Care Products during Water Recycling: Microbial Community Structure and Effects of Substrate Concentration

Removal of Emerging Contaminants in a Membrane Bioreactor Coupled with Ozonation: Optimization by Response Surface Methodology (RSM)

Comparative analysis of the removal and transformation of 10 typical pharmaceutical and personal care products in secondary treatment of sewage: A case study of two biological treatment processes

Removal of pharmaceutical and personal care products (PPCPs) from waterbody using a revolving algal biofilm (RAB) reactor

Analyzing microbial communities and their biodegradation of multiple pharmaceuticals in membrane bioreactors

PPCPs removal by aerobic granular sludge membrane bioreactor

Fate and Removal of Typical Pharmaceutical and Personal Care Products in a Wastewater Treatment Plant from Beijing: a Mass Balance Study

Removal of pharmaceuticals by ammonia oxidizers during nitrification

Combined use of strictly anaerobic MBBR and aerobic MBR for municipal wastewater treatment and removal of pharmaceuticals

A two-stage design enhanced biodegradation of high concentrations of a C16-alkyl quaternary ammonium compound in oxygen-based membrane biofilm reactors

Biodegradation of Emerging Pharmaceuticals from Domestic Wastewater by Membrane Bioreactor: The Effect of Solid Retention Time

Removals of pharmaceutical compounds at different sludge particle size fractions in membrane bioreactors operated under different solid retention times

Biological Performance and Fouling Mitigation in the Biochar-Amended Anaerobic Membrane Bioreactor (anmbr) Treating Pharmaceutical Wastewater

Role of Ammonia-Oxidizing Microorganisms in the Removal of Organic Micropollutants During Simulated Riverbank Filtration.

Effects of High Pharmaceutical Concentrations in Domestic Wastewater on Membrane Bioreactor Treatment Systems: Performance and Microbial Community

Occurrence and fate of pharmaceuticals and personal care products in a wastewater treatment plant with Bacillus bio-reactor treatment

Enhancement of PPCPs Removal by Shaped Microbial Community of Aerobic Granular Sludge under Condition of Low C/N Ratio Influent.